SCIENTIFIC BACKGROUND

BRCA1, BRCA2, BRIP1, ERCC4, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, MAD2L2, PALB2, RAD51, RAD51C, RFWD3, SLX4, UBE2T, XRCC2

Scientific Background

Fanconi anemia is a clinically and genetically heterogeneous group of diseases that have the following features in common: a pre- and postnatal growth disorder; malformations of the heart, kidneys and skeleton, in particular radial and thumb malformations; pigmentation abnormalities; characteristic facial features and microcephaly of variable severity. Early bone marrow failure with an increased risk of leukemia and solid tumors, is characteristic. This is ultimately caused by a DNA repair defect, which causes increased sensitivity, especially to DNA crosslinking agents, and leads to genomic instability. Accordingly, there is increased chromosomal fragility with mitomycin C or diepoxybutane. More than 20 subtypes with pathogenic genes have been described, whereby more than half of the diseases are due to pathogenic variants in FANCA. Inheritance is mostly autosomal recessive, rarely autosomal dominant (FANCR – RAD51) or X-linked recessive (FANCB – FANCB). There are no genotype-phenotype correlations.

 

Regular (annual) screening examinations (bone marrow, interdisciplinary examinations to exclude solid tumors) are recommended for monitoring. Treatment involves the use of oral androgens to increase the number of red blood cells and platelets as well as G-CSF to increase the number of neutrophils. Stem cell transplantation can correct bone marrow deficiency, but not the increased risk of solid tumors.

 

References

Fiesco-Roa et al. 2019, Blood Rev 37:100589 / Nalepa et Clapp 2018, Nat Rev Cancer 18:168 / Nepal et al. 2017, Trends Cancer 3:840 / Ebens et al. 2017, Expert Rev Hematol 10:81 / Mamrak et al. 2017, Blood Rev 31:93 / Cheung et Taniguchi 2017, Int J Hematol 106:335 / Esteban-Jurado et al. 2016, Eur J Hum Genet 24:1501 / Alter 2014, Best Pract Res Clin Haematol 27:214

 

GENES

BRCA1, BRCA2, BRIP1, ERCC4, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, MAD2L2, PALB2, RAD51, RAD51C, RFWD3, SLX4, UBE2T, XRCC2
How to order

LATEST ARTICLES

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more

Here you can read the winning essays from the first, annual DNA essay competition on the subject of "How unfolding the DNA code can help with precisi...

Read more

Introduction Our voices are as unique as our fingerprints! Although there are people whose voices might sound alike, there are no two voices exact...

Read more

Not everyone likes winter. For people who do not enjoy the cold weather, or having to put on a thick coat to go outside, a winter can be a source of ...

Read more